Tag: Binoy Gardi
“Biologics and biosimilars represent Veeda’s second-highest strategic priority after clinical trials”
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans